Haematologica Early View: Omid Seidizadeh Explores Genetics Behind Clinical Variability in Type 2 VWD
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, has shared a post on LinkedIn:
“Delighted to see our study on the genetic determinants of clinical variability in type 2 von Willebrand disease now out as Early View in Haematologica Journal
This work highlights how VWF genetic variation influences the clinical expression of different types 2 VWD, and the clinical variability among cases with the same genetic variant.”
Title: Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotype
Authors: Omid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, Paola Colpani, Andrea Cairo, Simona Maria Siboni, Flora Peyvandi
Read the article here.
Stay updated in the bleeding disorders field with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy